• If you are wondering whether MaxLinear's recent share price move has left the stock looking expensive or still potentially interesting, the valuation story is where your attention should be.
• The stock last closed at US$82.37, with returns of 16.4% over 7 days, 347.4% over 30 days, 345.0% year to date and a very large 1 year gain that is more than 6x.
• These moves sit against a backdrop of ongoing interest in semiconductor stocks, with investors watching closely for updates on demand for connectivity, broadband and data center related products. Sector news and sentiment can play a big role in how quickly expectations get baked into prices, which matters when you are judging whether the recent run up still leaves room for a reasonable entry point.
• MaxLinear currently has a valuation score of 1 out of 6. It is therefore worth looking at what different valuation methods say about this stock and then finishing with a more complete way to think about value that goes beyond any single model.

MaxLinear scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: MaxLinear Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model takes estimates of the cash MaxLinear could generate in the future and then discounts those cash flows back into today’s dollars to arrive at an estimated intrinsic value per share.

For MaxLinear, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is reported at $0.70 million. Analyst-based projections feed into the early years, with Simply Wall St extrapolating further out. By 2028, projected free cash flow is $140.83 million, with a series of annual estimates between 2026 and 2035 that are discounted back to today.

Putting these cash flows together, the DCF output suggests an estimated fair value of about $15.74 per share. Against the recent share price of $82.37, this implies the stock is 423.3% overvalued according to this model, which is a wide gap that readers should treat as a clear warning signal rather than a subtle nuance.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests MaxLinear may be overvalued by 423.3%. Discover 51 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: MaxLinear Price vs Sales

For companies where profits are limited or volatile, the P/S ratio is often a more useful guide than P/E because it compares the stock price to revenue rather than earnings, which can swing around from year to year.

In general, higher growth expectations and lower perceived risk can justify a higher “normal” P/S multiple, while slower expected growth or higher risk usually line up with a lower multiple. That is why looking at context is important rather than treating any single number as good or bad.

MaxLinear currently trades on a P/S of 14.49x. This sits above the Semiconductor industry average P/S of 8.65x and also above the peer average of 6.16x. Simply Wall St’s Fair Ratio for MaxLinear is 17.19x, which is its proprietary estimate of what a reasonable P/S might be given factors such as the company’s earnings growth profile, profit margin, industry, market cap and risk characteristics.

The Fair Ratio is more tailored than a simple peer or industry comparison because it adjusts for those company specific features rather than assuming all stocks should trade at similar levels. Comparing MaxLinear’s current 14.49x P/S with the 17.19x Fair Ratio indicates that the stock may be undervalued on this metric.

Result: UNDERVALUED

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.

Upgrade Your Decision Making: Choose your MaxLinear Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so Narratives are introduced here as a simple way for you to attach a clear story about MaxLinear to the numbers you care about, such as fair value, future revenue, earnings and margins, then see how that story stacks up against the current share price.

A Narrative is your own view of how MaxLinear’s business could play out, linked directly to a financial forecast and a fair value, which makes it easier to compare your expectations to what the market is currently pricing in.

On Simply Wall St’s Community page, Narratives are available as an accessible tool used by millions of investors, helping you see different fair value estimates side by side and quickly check whether the price looks high or low versus each story.

Narratives are updated automatically when new information such as news, product announcements or earnings is added to the platform, so your fair value view can stay aligned with the latest data without you rebuilding a model from scratch.

For MaxLinear, for example, one investor might align with a cautious Narrative that points to a fair value around US$17.00. Another might lean toward a more optimistic view closer to US$27.50. Comparing those Narratives to the live share price can help each investor decide whether the stock looks closer to a buy, a hold or a sell in their own framework.

Do you think there's more to the story for MaxLinear? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.